1. Larsson L, Degens H, Li M, Salviati L, Lee YI, Thompson W, et al. Sarcopenia: aging-related loss of muscle mass and function. Physiol Rev. 2019; 99:427–511.
Article
2. Liguori I, Russo G, Aran L, Bulli G, Curcio F, Della-Morte D, et al. Sarcopenia: assessment of disease burden and strategies to improve outcomes. Clin Interv Aging. 2018; 13:913–27.
Article
3. Ju SH, Yi HS. Clinical features and molecular mechanism of muscle wasting in end stage renal disease. BMB Rep. 2023; 56:426–38.
Article
4. Setoyama D, Lee HY, Moon JS, Tian J, Kang YE, Lee JH, et al. Immunometabolic signatures predict recovery from thyrotoxic myopathy in patients with Graves’ disease. J Cachexia Sarcopenia Muscle. 2022; 13:355–67.
Article
5. Lee JC, Song BS, Kang YM, Kim YR, Kang YE, Lee JH, et al. Effect of thyroid-stimulating hormone suppression on muscle function after total thyroidectomy in patients with thyroid cancer. Front Endocrinol (Lausanne). 2021; 12:769074.
Article
6. Park BS, Yoon JS. Relative skeletal muscle mass is associated with development of metabolic syndrome. Diabetes Metab J. 2013; 37:458–64.
Article
7. Tian J, Chung HK, Moon JS, Nga HT, Lee HY, Kim JT, et al. Skeletal muscle mitoribosomal defects are linked to low bone mass caused by bone marrow inflammation in male mice. J Cachexia Sarcopenia Muscle. 2022; 13:1785–99.
Article
8. Nilwik R, Snijders T, Leenders M, Groen BB, van Kranenburg J, Verdijk LB, et al. The decline in skeletal muscle mass with aging is mainly attributed to a reduction in type II muscle fiber size. Exp Gerontol. 2013; 48:492–8.
Article
9. Verdijk LB, Koopman R, Schaart G, Meijer K, Savelberg HH, van Loon LJ. Satellite cell content is specifically reduced in type II skeletal muscle fibers in the elderly. Am J Physiol Endocrinol Metab. 2007; 292:E151–7.
Article
10. Smerdu V, Karsch-Mizrachi I, Campione M, Leinwand L, Schiaffino S. Type IIx myosin heavy chain transcripts are expressed in type IIb fibers of human skeletal muscle. Am J Physiol. 1994; 267(6 Pt 1):C1723–8.
Article
11. Casey A, Constantin-Teodosiu D, Howell S, Hultman E, Greenhaff PL. Metabolic response of type I and II muscle fibers during repeated bouts of maximal exercise in humans. Am J Physiol. 1996; 271(1 Pt 1):E38–43.
Article
12. Wang Y, Pessin JE. Mechanisms for fiber-type specificity of skeletal muscle atrophy. Curr Opin Clin Nutr Metab Care. 2013; 16:243–50.
Article
13. Li S, Schonke M, Buurstede JC, Moll TJ, Gentenaar M, Schilperoort M, et al. Sexual dimorphism in transcriptional and functional glucocorticoid effects on mouse skeletal muscle. Front Endocrinol (Lausanne). 2022; 13:907908.
Article
14. Monaco CM, Bellissimo CA, Hughes MC, Ramos SV, Laham R, Perry CG, et al. Sexual dimorphism in human skeletal muscle mitochondrial bioenergetics in response to type 1 diabetes. Am J Physiol Endocrinol Metab. 2020; 318:E44–51.
Article
15. Smith GI, Mittendorfer B. Sexual dimorphism in skeletal muscle protein turnover. J Appl Physiol (1985). 2016; 120:674–82.
Article
16. Schneider AM, Mucharraz C, Denyer S, Brown NM. Prolonged hospital stay after arthroplasty for geriatric femoral neck fractures is associated with increased early mortality risk after discharge. J Clin Orthop Trauma. 2022; 26:101785.
Article
17. Hayes WC, Myers ER, Morris JN, Gerhart TN, Yett HS, Lipsitz LA. Impact near the hip dominates fracture risk in elderly nursing home residents who fall. Calcif Tissue Int. 1993; 52:192–8.
Article
18. Banks E, Reeves GK, Beral V, Balkwill A, Liu B, Roddam A, et al. Hip fracture incidence in relation to age, menopausal status, and age at menopause: prospective analysis. PLoS Med. 2009; 6:e1000181.
Article
19. Frontera WR, Suh D, Krivickas LS, Hughes VA, Goldstein R, Roubenoff R. Skeletal muscle fiber quality in older men and women. Am J Physiol Cell Physiol. 2000; 279:C611–8.
Article
20. Melton LJ 3rd, Khosla S, Crowson CS, O’Connor MK, O’Fallon WM, Riggs BL. Epidemiology of sarcopenia. J Am Geriatr Soc. 2000; 48:625–30.
Article
21. Dao T, Green AE, Kim YA, Bae SJ, Ha KT, Gariani K, et al. Sarcopenia and muscle aging: a brief overview. Endocrinol Metab (Seoul). 2020; 35:716–32.
Article
22. Kramer IF, Snijders T, Smeets JS, Leenders M, van Kranenburg J, den Hoed M, et al. Extensive type II muscle fiber atrophy in elderly female hip fracture patients. J Gerontol A Biol Sci Med Sci. 2017; 72:1369–75.
Article
23. Nuzzo JL. Sex differences in skeletal muscle fiber types: a meta-analysis. Clin Anat. 2024; 37:81–91.
Article
24. Ahn SH, Jung HW, Lee E, Baek JY, Jang IY, Park SJ, et al. Decreased serum level of sclerostin in older adults with sarcopenia. Endocrinol Metab (Seoul). 2022; 37:487–96.
Article
25. Choi JH, Seo JW, Lee MY, Lee YT, Yoon KJ, Park CH. Association between elevated plasma homocysteine and low skeletal muscle mass in asymptomatic adults. Endocrinol Metab (Seoul). 2022; 37:333–43.
Article
26. Jung HW, Park JH, Kim DA, Jang IY, Park SJ, Lee JY, et al. Association between serum FGF21 level and sarcopenia in older adults. Bone. 2021; 145:115877.
Article
27. Nga HT, Jang IY, Kim DA, Park SJ, Lee JY, Lee S, et al. Serum GDF15 level is independent of sarcopenia in older Asian adults. Gerontology. 2021; 67:525–31.
Article